The US market for foods and beverages featuring hemp-derived CBD – from relaxation drinks to gummies – could be worth $2.5bn by 2023, or 10.5% of an estimated $23.7bn market for CBD products (spanning everything from pharmaceuticals to petfood), predicts...
An interim final rule on CBD is a viable way for FDA to break the logjam on this increasingly popular ingredient, according to the head of one industry trade organization.
China’s State Administration for Market Regulation (SAMR) is encouraging health food firms to contribute to the expansion of the Health Food Raw Materials Directory by presenting evidence to support the functional efficacy of ingredients to the unit.
Oregon Sen. Ron Wyden has put further pressure on FDA with a letter requesting a formal announcement of enforcement discretion on the CBD question while a more permanent regulatory solution is hashed out.
By the end of 2019, 98% of food and beverage products will have adopted a standardized version of date labeling – ‘Best If Used By' – with complete adoption anticipated by January 2020, predict the Grocery Manufacturers Association (GMA) and the...
There are several ingredient lists on FDA’s website that imply some sort of warning to the public. But what's the criteria that decides into which list an ingredient will fall?
An amendment advocated by the Natural Products Association that would earmark funds for CBD regulation was including in the final version of the 2019 appropriations bill passed by the US House of Representatives.
Natural products online marketplace Thrive Market has temporarily halted sales of hemp-derived CBD products after its merchant processor demanded it cease selling them amid uncertainty over their legal status, but says it is in conversations with a new...
The US Food and Drug Administration has approved a list of qualified health claims for omega-3 fatty acids and their effect on blood pressure, culminating a five year plus effort on the part of industry.
An amendment to the National Defense Authorization Act (NDAA) introduced to Congress would require the creation of a reporting system for adverse events that may be associated with dietary supplements use in the military. Trade group CRN is pushing back,...
Congress should act to create a new law to solve the CBD (cannabidiol) regulatory issue, while simultaneously “closing long-standing gaps” in the oversight of all dietary supplements, according to a new paper by Dr Pieter Cohen and Dr Joshua Sharfstein.
The European Food and Safety Authority (EFSA) finds no safety concerns with the Novel Food (NF) phenylcapsaicin, a synthetic chemical compound of the chili pepper extract capsaicin.
Controversy swirls around whether dietary supplement brands should be required to register the products they have on the market with FDA. Two attorneys debated the risks and benefits of a mandatory product registry yesterday at the CRN/ACI Annual Legal,...
US Rep. Jerry McNerney (D-CA) last week filed an amendment to modify the House Agriculture appropriations bill to include critical funds that would enable FDA to undertake the appropriate processes and set a safe level of CBD.
The growing popularity of nootropics and sports nutrition supplements is leading to a boom in unlicensed products being sold online, with Australia's Therapeutic Goods Administration (TGA) recently seizing a raft of items.
The IPA World Congress + Probiota Americas 2019 in Vancouver is less than two weeks away, but there’s still time to register to hear from must-see speakers from the Alan Alda Center for Communicating Science, the US Army, Danone, Pharmavite, and many...
The United States Anti Doping Agency has named NSF Certified for Sport as the dietary supplement certification that best meets the needs of athletes, the organization announced recently.
Lessons learned from the history of the dietary supplement industry can be applied to the hemp world, and the blitzkrieg-like pace of the industry means we’ll know in short order who’s getting the message and who isn’t. It will also put pressure on regulators...
A new SNAP Vitamin and Mineral Improvement Act was introduced in both the Senate and House this week, reviving the cause after language from a similar act was dropped in the Farm Bill that passed last year.
A new analysis of FDA adverse event data that calls for reduced access to dietary supplements for children, adolescents, and young adults has been slammed by a leading expert in adverse event reporting.
Pet owners are more likely to support the legalization of marijuana than the overall population, according to a recent Packaged Facts survey. They’re also more likely to agree that both prescription and OTC hemp, CBD, and cannabis products should be legal.
The US Food and Drug Administration issued a warning on Monday advising pregnant women to avoid the use of dietary supplements containing the ingredient vinpocetine. Industry stakeholders wondered if the missive has more to do with ingredient’s regulatory...
Presentations at the recent FDA meeting on CBD outlined the concerns some academics in the field have about the quality and safety of the products that are on the market.
The European Commission (EC) releases a report offering scientific guidance to help meet the growing global demand for seaweed species now accepted as novel food.
A joint webinar put on by Global Organization of EPA and DHA Omega 3s (GOED) and the United Natural Products Alliance (UNPA) will help companies understand the intentional adulteration provisions of FSMA.
Friday’s public meeting was an illuminating day of presentations, with multiple viewpoints and interests being aired. On the dietary supplements side, there were strong calls for companies to take the front door with the Agency.
Researchers in Israel reported that participants in a dieting study who showed greater Body Mass Index (BMI) decreases had higher potassium intakes than those with modest BMI decreases.
When it comes to legally marketing conventional food and dietary supplements with CBD and other cannabis-derived compounds, FDA and industry appear stuck in a catch-22.
Advocates are unanimous in saying that natural products could always benefit from more research. But what about when that research looks at disease endpoints?
Early returns from the FDA meeting on CBD regulation give a glimpse of the complexity of the regulatory questions, which might stretch the timeline for a new legal framework to extent beyond which many in the industry would find acceptable.
Frustration filled the air at the Dietary Supplements Regulatory Summit earlier this month when it became apparent that no progress has been made in the industry’s push for FDA to drop weight requirements on probiotic product labels.
“If we do not succeed in working together to reassure the card brands that they can safely support our industry, then we predict a significant decrease in CBD sales within the next few months,” the National Cannabis Industry Association (NCIA) has warned.
The main purpose of the Botanical Safety Consortium, a public-private effort bringing together stakeholders in the botanical supplements space, is “advancing the science of botanical safety evaluation, [and is] not involved in regulatory decisions or...
A new force is shaping the dietary supplement market, one that operates largely outside of normal industry channels. The growth of the online sales channel, and brands that operate exclusively in that space, is an increasingly powerful force.
A study published recently has found a level of liver toxicity for CBD, putting up a big caveat to the notion within the hemp/CBD world that its products have nothing in the way of safety concerns.
The time is now for industry to voluntarily improve the transparency of probiotic product quality, even in the absence of regulatory requirements, says a recent review.
Italy’s National Institute of Health reports a further six new hepatitis incidences linked to the consumption of turmeric-based food supplements bringing the total to ten cases.
It was a who’s who of the dietary supplement world in College Park for the FDA public meeting on responsible innovation in dietary supplements. Here are some of the key comments:
Despite comments made by then FDA Commissioner Scott Gottlieb to the contrary, the US Food and Drug Administration does not have a policy of enforcement discretion with respect to products derived from cannabis and its components, including cannabidiol...
Italy’s National Institute of Health has received further notifications of two more hepatitis cases linked to a turmeric-based food supplement distributed by a firm already implicated in two similar incidents earlier this month.
What do housing crises and dietary supplement recalls have in common? They cause a big bust to consumer trust, said Frank Yiannas, deputy commissioner for food policy and response at the Food and Drug Administration.
The European Industrial Hemp Association (EIHA) has described regulatory measures taken against CBD-containing products as “disproportionate and senseless,” in moves that have bought “negative consequences”.
The 2015 Dietary Guidelines prompted a heated debate over the influence of industry lobby groups and the extent to which environmental factors should impact dietary advice, with some stakeholders insisting that sustainability has nothing to do with nutrition,...
